Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 11, 2021Nature CommunicationsOpen Access

A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSisi KangSun Yat-sen UniversityMYMei YangZhejiang Chinese Medical UniversitySHSuhua HeNorthwestern Polytechnical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kang et al. (2021) studied this question.

synapsesocial.com/papers/6aadef754f81410a84b8b532https://doi.org/10.1038/s41467-021-23036-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity2020 · 146 citations
  2. 2Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020 · 21,248 citations
  3. 3A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-22020 · 1,585 citations